project . 2021 - 2024 . On going
SISAQOL-IMI
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
Open Access mandate for Publications and Research DataOpen Access mandate for ... European Commission
- Funder: European CommissionProject code: 945052 Call for proposal: H2020-JTI-IMI2-2019-18-two-stage
- Funded under: H2020 | IMI2-RIA Overall Budget: 5,944,760 EURFunder Contribution: 2,281,840 EUR
- Status: On going
- Start Date01 Jan 2021End Date31 Dec 2024
Partners
MODUS OUTCOMES SAS, AbbVie, Leiden University Medical Center, Queen's University at Kingston, University Medical Center Freiburg, Ghent University, Oslo University Hospital, BII GMBH, Bayer AG, PFIZER, Critical Path Institute, MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN, University of Leeds, MUI, EORTC, JHU, University of Birmingham, NORWEGIAN MEDICINES AGENCY, KUL, REGIONH, ...
Partners
MODUS OUTCOMES SAS, AbbVie, Leiden University Medical Center, Queen's University at Kingston, University Medical Center Freiburg, Ghent University, Oslo University Hospital, BII GMBH, Bayer AG, PFIZER, Critical Path Institute, MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN, University of Leeds, MUI, EORTC, JHU, University of Birmingham, NORWEGIAN MEDICINES AGENCY, KUL, REGIONH, ...